After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of Neurocrine Biosciences, Inc is $9.51B. A total of 1.77 million shares were traded on the day, compared to an average of 1.45M shares.
In the most recent transaction, Cooke Julie sold 1,551 shares of NBIX for 116.78 per share on Feb 13 ’25. After the transaction, the Chief Human Resources Officer now owns 19,544 company shares. In a previous transaction on Feb 13 ’25, GORMAN KEVIN CHARLES sold 5,844 shares at 116.69 per share. NBIX shares that Director owns now total 521,618.
Among the insiders who sold shares, SHERWIN STEPHEN A disposed of 13,831 shares on Feb 13 ’25 at a per-share price of $116.69. This resulted in the Director holding 10,673 shares of NBIX after the transaction. In another insider transaction, ROBERTS EIRY sold 1,718 shares at $116.85 per share on Feb 13 ’25. Company shares held by the Chief Medical Officer now total 34,252.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, NBIX has a high of $157.98 and a low of $84.23.
As of this writing, NBIX has an earnings estimate of $1.19 per share for the current quarter. EPS was calculated based on a consensus of 14.0 estimates, with a high estimate of $1.82 per share and a lower estimate of $0.15.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. NBIX’s latest balance sheet shows that the firm has $711.30M in Cash & Short Term Investments as of fiscal 2021. There were $440.40M in debt and $245.80M in liabilities at the time. Its Book Value Per Share was $26.05, while its Total Shareholder’s Equity was $1.37B.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NBIX is Buy with a score of 4.65.
